- English (USA)
- English (UK)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Sigma Pharmaceuticals Ltd (SIG)
Sigma Pharmaceuticals Ltd stock price live, this page displays ASX SIG stock exchange data. View the SIG premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Sigma Pharmaceuticals Ltd real time stock price chart below.
What Is the Sigma Pharmaceuticals Ltd Stock Price Today?
The Sigma Pharmaceuticals Ltd stock price today is 2.670.
What Is the Stock Symbol for Sigma Pharmaceuticals Ltd?
The stock symbol for Sigma Pharmaceuticals Ltd is "SIG."
What Stock Exchange Does Sigma Pharmaceuticals Ltd Trade On?
Sigma Pharmaceuticals Ltd is listed and trades on the Sydney stock exchange.
Is Sigma Pharmaceuticals Ltd a Good Stock to Buy?
Determining whether Sigma Pharmaceuticals Ltd—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the SIG quote. (ISIN: AU000000SIG5)
What Is the Sigma Pharmaceuticals Ltd Stock Price Today?
The Sigma Pharmaceuticals Ltd stock price today is 2.670.
What Is the Stock Symbol for Sigma Pharmaceuticals Ltd?
The stock symbol for Sigma Pharmaceuticals Ltd is "SIG."
What Stock Exchange Does Sigma Pharmaceuticals Ltd Trade On?
Sigma Pharmaceuticals Ltd is listed and trades on the Sydney stock exchange.
Is Sigma Pharmaceuticals Ltd a Good Stock to Buy?
Determining whether Sigma Pharmaceuticals Ltd—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the SIG quote. (ISIN: AU000000SIG5)
Sydney
Currency in AUD
2.670
-0.010(-0.37%)
Closed·
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
2.650
2.690
52 wk Range
2.580
3.200
SIG is not included in our AI-picked strategies. See which stocks are.
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
2.6502.690
52 wk Range
2.5803.200
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
(1.49%)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
(1.49%)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
SIG Scorecard
Company’s Health
Assesses a company's financial position by analyzing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Sell
Price Target
3.198
Upside
+19.78%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Trading at a high P/E ratio relative to near-term earnings growth
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Sell
Technical Indicators
Sell
Moving Averages
Sell
Analyst Ratings
11 Buy
5 Hold
0 Sell
Ratings:
16 analysts
Overall Consensus
Buy
Analysts 12-Month Price Target:
Average 3.198
(+19.78% Upside)
Sigma Pharmaceuticals Ltd Earnings Call Summary for H2/2026
- Sigma Healthcare reported FY2026 revenue up 15.5% to AUD 10.8B, normalized EBIT rose 20.6% to AUD 1.098B, and NPAT increased 22.3% to AUD 732.3M.
- Shares fell 6.16% to $2.665 despite strong results, as investors focused on widened cash conversion cycle, integration costs, and UK startup losses.
- Company achieved AUD 32M of AUD 100M annualized synergy target from Chemist Warehouse merger, with remainder expected through FY2029.
- Management forecasts continued double-digit like-for-like sales growth driven by GLP-1 demand, with 74 store openings/refurbishments planned for H1 FY2027.
- International operations EBIT nearly doubled with Ireland achieving first profit; 561 Chemist Warehouse stores generated AUD 10B in network sales.
Last Updated: 08/27/2026, 09:20 AM
Read Full TranscriptEarnings
Latest Release
Aug 26, 2026
EPS / Forecast
0.03 / --
Revenue / Forecast
5.33B / --
Compare SIG to Peers and Sector
Metrics to compare | SIG | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipSIGPeersSector | |
|---|---|---|---|---|
P/E Ratio | 43.1x | 15.8x | −0.4x | |
PEG Ratio | 1.98 | 0.01 | 0.00 | |
Price/Book | 6.1x | 1.3x | 2.6x | |
Price / LTM Sales | 2.8x | 0.9x | 3.0x | |
Upside (Analyst Target) | 19.4% | 22.6% | 49.7% | |
Fair Value Upside | Unlock | 31.6% | 6.8% | Unlock |
Sigma Healthcare Limited operates as a retail pharmacy franchisor and pharmaceutical wholesale and distributor to community pharmacies in Australia, and internationally. It is involved in the wholesale distribution of pharmaceutical, medical, healthcare and beauty products to a network of franchised retail pharmacies, and other third parties; advertising and marketing services; and provision of support services to a network of retail pharmacies. The company also provides MPS Connect, a end-to-end medication management solution. The company operates stores under the Chemist Warehouse, Amcal, and Discount Drug stores, and PriceSave brand names. It also offers products online. The company was founded in 1912 and is headquartered in Preston, Australia.
Ownership
Ownership Overview
Top Holders
People Also Watch
FAQ
What Is the Sigma Pharma (SIG) Stock Price Today?
The Sigma Pharma stock price today is 2.670 AUD.
What Stock Exchange Does Sigma Pharma Trade On?
Sigma Pharma is listed and trades on the Sydney Stock Exchange.
What Is the Stock Symbol for Sigma Pharma?
The stock symbol for Sigma Pharma is "SIG."
Does Sigma Pharma Pay Dividends? What’s The Current Dividend Yield?
The Sigma Pharma dividend yield is 1.49%.
What Is the Sigma Pharma Market Cap?
As of today, Sigma Pharma market cap is 30.830B AUD.
What Is Sigma Pharma's Earnings Per Share (TTM)?
The Sigma Pharma EPS (TTM) is 0.062.
From a Technical Analysis Perspective, Is SIG a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.
How Many Times Has Sigma Pharma Stock Split?
Sigma Pharma has split 2 times.
What is the current trading status of Sigma Pharma (SIG)?
As of Sep 09, 2026, Sigma Pharma (SIG) is trading at a price of 2.670 AUD, with a previous close of 2.680 AUD. The stock has fluctuated within a day range of 2.650 AUD to 2.690 AUD, while its 52-week range spans from 2.580 AUD to 3.200 AUD.
What Is Sigma Pharma (SIG) Price Target According to Analysts?
The average 12-month price target for Sigma Pharma is 3.198 AUD, with a high estimate of 3.8 AUD and a low estimate of 2.6 AUD. 11 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Buy. The stock has an +19.78% Upside potential.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.